Division of AstraZeneca PLC
Latest From Cellective Therapeutics
The UK-based pharma’s corporate venture arm now has $400 million under management in an evergreen fund, with an expanded global focus that includes health care information technology.
- Large Molecule
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- AstraZeneca PLC
- Senior Management
- Arthur M Mandell, Pres. & CEO
- Contact Info
Durham, NC 27312
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.